Cargando…

Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma

Background: Gliomablastoma multiforme (GBM) is the most fatal form of all brain cancers in human with no successful treatment available. Programmed death-ligand 1 (PD-L1) is a coinhibitory ligand predominantly expressed by tumor cells. Growth differentiation factors (GDFs) are a subfamily of protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Haiqin, Li, Zhanzhan, Fu, Jun, Zhou, Rongrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497826/ https://www.ncbi.nlm.nih.gov/pubmed/31114328 http://dx.doi.org/10.2147/CMAR.S192095

Ejemplares similares

Clinical value of a plasma Epstein–Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis
por: Peng, Haiqin, et al.
Publicado: (2019)

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017)

Paliperidone Inhibits Glioblastoma Growth in Mouse Brain Tumor Model and Reduces PD-L1 Expression
por: Liu, Yu-Shu, et al.
Publicado: (2021)

Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells
por: Li, Zhanzhan, et al.
Publicado: (2018)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

PD-L1: expression regulation
por: Zhou, Yu-Jie, et al.
Publicado: (2023)

Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
por: Sharma, Gitanjali, et al.
Publicado: (2023)

PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2021)

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
por: Derer, Anja, et al.
Publicado: (2016)

PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells
por: Tufano, Martina, et al.
Publicado: (2021)

PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway
por: Mirzaei, Reza, et al.
Publicado: (2021)

Growth Differentiation Factor 15 Is Associated With Alzheimer’s Disease Risk
por: Wu, Peng-Fei, et al.
Publicado: (2021)

Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
por: Mo, Zhongfu, et al.
Publicado: (2016)

Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo
por: Martomo, Stella A., et al.
Publicado: (2022)

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
por: Zhang, Xingming, et al.
Publicado: (2019)

ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
por: Tong, Luqing, et al.
Publicado: (2020)

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
por: Kowanetz, Marcin, et al.
Publicado: (2018)

The prognostic significance of PD-L1 expression in patients with glioblastoma: A meta-analysis
por: Guo, Xin, et al.
Publicado: (2022)

New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection
por: Korbecki, Jan, et al.
Publicado: (2018)

Methylome Profiling of PD-L1-Expressing Glioblastomas Shows Enrichment of Post-Transcriptional and RNA-Associated Gene Regulation
por: Hutarew, Georg, et al.
Publicado: (2022)

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
por: Han, Jiheun, et al.
Publicado: (2017)

GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors
por: Fu, Yujie, et al.
Publicado: (2020)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
por: Wang, Xin, et al.
Publicado: (2019)

Role of regulation of PD-1 and PD-L1 expression in sepsis
por: Zhang, Teng, et al.
Publicado: (2023)

PD-1/PD-L1 regulates Treg differentiation in pregnancy-induced hypertension
por: Jiang, Lai, et al.
Publicado: (2018)

Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis
por: WEI, BO, et al.
Publicado: (2015)

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
por: Garcia-Diaz, Angel, et al.
Publicado: (2017)

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
por: Rotman, Jossie, et al.
Publicado: (2020)

Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide
por: Lee, Gilbert Aaron, et al.
Publicado: (2021)

The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive Patients
por: Xue, Hao, et al.
Publicado: (2012)

β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
por: Du, Linyong, et al.
Publicado: (2020)

Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy
por: Weng, Shao-Wen, et al.
Publicado: (2022)

GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
por: Korur, Serdar, et al.
Publicado: (2009)

Growth Differentiation Factor-15 in Immunity and Aging
por: Pence, Brandt D.
Publicado: (2022)

The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
por: Chu, Xianjing, et al.
Publicado: (2022)

Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma
por: Zhao, Ju, et al.
Publicado: (2022)

Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
por: Chu, Xianjing, et al.
Publicado: (2023)

Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
por: Luo, Jing, et al.
Publicado: (2023)

Regulation of PD-L1 expression in the tumor microenvironment
por: Yi, Ming, et al.
Publicado: (2021)

Regulation of PD-L1 Expression by Nuclear Receptors
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kltqq99nd4a8v2htfb278halc0